Comparing the effect of Aromatase inhibitor (Letrozol) + Cabergoline (Dostinex) and letrozol alone on uterine myoma regressio
Phase 1
- Conditions
- terine myoma.Leiomyoma of uterus, unspecified
- Registration Number
- IRCT201506205283N12
- Lead Sponsor
- Vice chancellor for Research,Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 76
Inclusion Criteria
women with Myoma larger than 4 cm and irregular menstrual cycle; Candidate for myomectomy or hysterectomy or treatment of infertility
Exclusion criteria: Age over 45 years; Uterine disease; Kidney disease; Liver disease; Antipsychotic drugs; Patients with history of use estrogen and progesterone in the last month; Patients with a history of drug treatment or surgery for uterine myoma and uterine bleeding
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deterioration of uterine myoma. Timepoint: 12 weeks after starting treatment. Method of measurement: Ultrasound.
- Secondary Outcome Measures
Name Time Method Menstrual regulation. Timepoint: After treatment. Method of measurement: Questionnaire.